By submitting my Email address I confirm that I have read and accepted the Terms of Use and Declaration of Consent.

By submitting your personal information, you agree that TechTarget and its partners may contact you regarding relevant content, products and special offers.

You also agree that your personal information may be transferred and processed in the United States, and that you have read and agree to the Terms of Use and the Privacy Policy.

In the face of increasingly sophisticated methods for avoiding detection, the company is hoping legal action can eradicate offenders where technology has failed.

Google has filed a lawsuit in a US federal court against advertisers that have broken its rules, according to Michael Zwibelman, litigation counsel at Google.

"Despite our best efforts - from extensive verification procedures, to automated keyword blocking, to changing our ads policies - a small percentage of pharma ads from these rogue companies is still appearing on Google," he wrote in a company blog post.

Google plans to add offenders to the lawsuit as they are identified.

"Rogue pharmacies are bad for our users, for legitimate online pharmacies and for the entire e-commerce industry, so we are going to keep investing time and money to stop these kinds of harmful practices," wrote Zwibelman.

The move comes just days after eNom, the world's second-largest seller of website addresses, announced it would begin screening applicants to block bogus online pharmacies.

In response to growing pressure from US authorities and internet governance group Icann, eNom has teamed up with LegitScript, a company that vets internet pharmaceutical concerns to make sure they are licensed to do business in the US.

LegitScript will enable eNom to identify applicants who are operating online pharmacies in violation of US state or federal law.

0 comments

Register

Login

Forgot your password?

Your password has been sent to:

By submitting you agree to receive email from TechTarget and its partners. If you reside outside of the United States, you consent to having your personal data transferred to and processed in the United States. Privacy